Skip to content

Clinical observation of therapeutic effect on alopecia areata by cold atmospheric plasma combined with mesotherapy

Clinical observation of therapeutic effect on alopecia areata by cold atmospheric plasma combined with mesotherapy

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200059618
Enrollment
Unknown
Registered
2022-05-04
Start date
2022-05-05
Completion date
Unknown
Last updated
2024-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

alopecia areata

Interventions

Group A:CAP combined with mesotherapy
Group B:Saline combined with mesotherapy

Sponsors

Department of Dermatology, The Second Affiliated Hospital of Xi'an Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. The age range is 14-65 years old, regardless of gender; 2. Patients diagnosed as alopecia areata according to clinical manifestations and dermoscopic signs; 3. Vital signs are stable; 4. The subject has signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. The clinical symptoms and skin lesions of the patient are confirmed not to meet the diagnostic criteria for alopecia areata; 2. Have other active skin diseases that may affect the evaluation of the disease; 3. Other types of alopecia, such as androgenic alopecia; 4. Within 4 weeks, he has systematically received the treatment of investigational drugs, biological agents and immunosuppressants, and within 2 weeks, he has received the treatment of topical glucocorticoids and phototherapy; 5. Allergic to CAP; 6. Patients who quit midway for some reason or did not follow the established experimental plan; 7. Have a history of hepatitis B or C; Or HIV antibody positive; 8. Have a history of serious systemic diseases or malignant tumors; 9. Pregnant women and lactating women; 10. Other circumstances in which the researcher considers it inappropriate to participate in the test.

Design outcomes

Primary

MeasureTime frame
Severity of Alopecia Tool;Dermatology Life Quality Index;

Contacts

Public ContactXia Yumin

Department of Dermatology, The Second Affiliated Hospital of Xi'an Jiaotong University

baidoudou0523@stu.xjtu.edu.cn+86 18891529053

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026